Company Filing History:
1 out of 1,745 
1 out of 141 
1 out of 5,094 
Years Active: 2025
Title: Grégory Bouchaud: Innovator in Allergy Treatment
Introduction
Grégory Bouchaud is a notable inventor based in Nantes, France. He has made significant contributions to the field of allergy treatment, particularly in understanding the role of PCSK9 in asthma and allergic diseases. His innovative work aims to address a global health burden that affects millions.
Latest Patents
Grégory Bouchaud holds a patent titled "Methods and compositions for treating asthma and allergic diseases." This invention explores the implications of PCSK9 on inflammation and its potential impact on allergies and asthma. Preliminary data from his research indicates that PCSK9 deficiency significantly increases the percentage of regulatory T cells in various immune tissues. His findings suggest that inhibitors of PCSK9 could be effective in treating asthma and food allergies.
Career Highlights
Throughout his career, Bouchaud has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the University of Nantes (Université De Nantes). His research has contributed to a deeper understanding of the mechanisms underlying allergic responses and asthma.
Collaborations
Grégory Bouchaud has collaborated with notable colleagues, including Bertrand Cariou and Antoine Magnan. These partnerships have enhanced the scope and impact of his research in the field of allergy treatment.
Conclusion
Grégory Bouchaud's innovative work in allergy treatment through his research on PCSK9 represents a significant advancement in addressing asthma and allergic diseases. His contributions continue to pave the way for new therapeutic approaches in this critical area of health.